Eli Lilly and Company Backs Haryana State FDA Action Against Counterfeit Drugs
Eli Lilly and Company supports Haryana State FDA action against counterfeit medicines, providing guidance on safe procurement and product identification to ensure patient safety and drug authenticity.
Haryana Drug Control Authority Actio | 01/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy